Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Trodusquemine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Trodusquemine?

Trodusquemine is an investigational drug.

There have been 4 clinical trials for Trodusquemine. The most recent clinical trial was a Phase 1 trial, which was initiated on May 1st 2007.

The most common disease conditions in clinical trials are Diabetes Mellitus, Breast Neoplasms, and Overweight. The leading clinical trial sponsors are Genaera Corporation, Northwell Health, and DepYmed Inc.

Recent Clinical Trials for Trodusquemine
Safety and Tolerability of MSI-1436C in Metastatic Breast CancerDepYmed Inc.Phase 1
Safety and Tolerability of MSI-1436C in Metastatic Breast CancerNorthwell HealthPhase 1
An Ascending Multi-Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic VolunteersGenaera CorporationPhase 1

See all Trodusquemine clinical trials

Clinical Trial Summary for Trodusquemine

Top disease conditions for Trodusquemine
Top clinical trial sponsors for Trodusquemine

See all Trodusquemine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.